Qlaris Bio is a clinical-stage biotechnology company focused on developing first-in-class therapies for ophthalmic diseases, with a mission to preserve vision and prevent blindness. Its lead candidate, QLS-111, uses a novel mechanism of action to lower intraocular pressure by targeting the distal outflow pathway, and is being evaluated for primary… - View it on GitHub